Palisade Bio Financials
| PALI Stock | USD 2.44 0.01 0.41% |
Palisade |
Understanding current and past Palisade Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Palisade Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Palisade Bio's assets may result in an increase in income on the income statement.
Palisade Bio Stock Summary
Palisade Bio competes with Zura Bio, Altamira Therapeutics, Immix Biopharma, Enveric Biosciences, and ZyVersa Therapeutics. Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. The company was founded in 2005 and is headquartered in Carlsbad, California. Palisade Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US6963894026 |
| CUSIP | 64127R302 64127R401 696389105 81689B103 696389204 64127R500 696389402 |
| Location | Maryland; U.S.A |
| Business Address | 7750 El Camino |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.palisadebio.com |
| Phone | 858 704 4900 |
| Currency | USD - US Dollar |
Palisade Bio Key Financial Ratios
| Return On Equity | -1.1 | ||||
| Return On Asset | -0.59 | ||||
| Target Price | 30.33 | ||||
| Beta | 1.33 |
Palisade Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Palisade Bio's current stock value. Our valuation model uses many indicators to compare Palisade Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Palisade Bio competition to find correlations between indicators driving Palisade Bio's intrinsic value. More Info.Palisade Bio is regarded third in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Palisade Bio's earnings, one of the primary drivers of an investment's value.Palisade Bio Systematic Risk
Palisade Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Palisade Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Palisade Bio correlated with the market. If Beta is less than 0 Palisade Bio generally moves in the opposite direction as compared to the market. If Palisade Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Palisade Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Palisade Bio is generally in the same direction as the market. If Beta > 1 Palisade Bio moves generally in the same direction as, but more than the movement of the benchmark.
About Palisade Bio Financials
What exactly are Palisade Bio Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Palisade Bio's income statement, its balance sheet, and the statement of cash flows. Potential Palisade Bio investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Palisade Bio investors may use each financial statement separately, they are all related. The changes in Palisade Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Palisade Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Palisade Bio November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Palisade Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Palisade Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Palisade Bio based on widely used predictive technical indicators. In general, we focus on analyzing Palisade Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Palisade Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 24.25 | |||
| Value At Risk | (8.55) | |||
| Potential Upside | 5.97 |
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |